Myoma;Uterus Clinical Trial
Official title:
Analysis of Surgical Outcomes in Women Undergoing Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens
Laparoscopic myomectomy represents the fertility-sparing gold standard approach for the management of subserosal and intramural uterine myomas: this technique allows faster recovery, less complications and improved surgical outcomes than laparotomy. Despite these validated cornerstones of minimally invasive gynecology, the best approach for specimen retrieval is still debated. Among these approaches, surgical specimen retrieval after laparoscopic myomectomy could be performed by mini-laparotomy, by power morcellation using morcellator inserted through one of the ancillary trocars, or by transvaginal extraction through an endobag inserted at level of the posterior vaginal fornix (between the utero-sacral ligaments). Unfortunately, mini-laparotomy has poor esthetic outcome and does not conform the current standards of minimally invasive surgery. In addition, on 24 November 24 2014 the Food and Drug Administration updated a Safety Communication about Power Morcellation, warning against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for treatment of fibroids, due to the risk of spreading an unsuspected uterine sarcoma within the abdomen and pelvis. Considering this scenario, transvaginal extraction may represents a feasible approach for specimen retrieval. In this view, the current study aims to retrospectively compare surgical outcomes in women that underwent laparoscopic myomectomy with subsequent power morcellation (before the issuing of the abovementioned Safety Communication by the Food and Drug Administration) or transvaginal extraction (after the issuing of the abovementioned Safety Communication by the Food and Drug Administration) of the surgical specimens.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
| Active, not recruiting |
NCT06114758 -
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
|
||
| Not yet recruiting |
NCT05932082 -
The Impact of Myomectomy on IVF Outcomes
|
N/A | |
| Not yet recruiting |
NCT05967936 -
Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy
|
N/A | |
| Recruiting |
NCT04748978 -
OPPIuM Technique and Myolysis With Diode Laser Dwls
|
N/A | |
| Recruiting |
NCT05271981 -
Fertility After Uterine Artery Embolization
|
||
| Completed |
NCT05025410 -
Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
|
||
| Recruiting |
NCT03483142 -
the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation
|
Phase 3 | |
| Completed |
NCT03533907 -
Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
|
||
| Completed |
NCT05811286 -
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
|
N/A | |
| Not yet recruiting |
NCT04364581 -
Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions
|
Phase 4 | |
| Recruiting |
NCT06067971 -
Evaluation of the Feasibility of Using Augmented Reality in Laparoscopic Surgery, by a Clinical Study During Gynecological Laparoscopic Surgical Procedures. (ENDORA2)
|
N/A | |
| Recruiting |
NCT04990076 -
Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
|
||
| Recruiting |
NCT06325501 -
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
|
Phase 3 | |
| Completed |
NCT05761418 -
Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy
|
Phase 3 | |
| Recruiting |
NCT04311073 -
Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies
|
Phase 3 | |
| Active, not recruiting |
NCT05930769 -
Retrospective Study on the Evaluation of the Impact of Augmented Reality Usage in Gynecological Laparoscopy on Patients Operated Between 2017 and 2021 (ImpactRA)
|
||
| Recruiting |
NCT03550703 -
Open Label Immunotherapy of Myoma
|
Phase 2 | |
| Completed |
NCT04482959 -
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
|
Phase 4 | |
| Not yet recruiting |
NCT04030273 -
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
|